ArticleInfectious diseases and therapy2024

Direct-Acting Antivirals Remain Cost-Effective Treatments for Chronic Hepatitis C in Australia Despite Changes to the Treated Population and the Availability of Retreatment: The Glecaprevir/Pibrentasvir (Maviret

Emma Warren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.